Strides Pharma Science Ltd (STAR) Financial Statements

3 Followers

Strides Pharma Science Ltd Financial Overview

Strides Pharma Science Ltd's market cap is currently ₹89.02B. The company's EPS TTM is ₹21.9; its P/E ratio is 10.27; and it has a dividend yield of 0.41%. Strides Pharma Science Ltd is scheduled to report earnings on January 30, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Income Statement
Total Revenue	₹ 44.75B	₹ 38.28B	₹ 36.68B	₹ 30.59B	₹ 32.80B
Gross Profit	₹ 11.83B	₹ 8.51B	₹ 8.05B	₹ 4.11B	₹ 9.59B
Operating Income	₹ 5.18B	₹ 3.02B	₹ 1.24B	₹ -2.52B	₹ 3.15B
EBITDA	₹ 7.10B	₹ 5.15B	₹ 3.66B	₹ -214.95M	₹ 5.17B
Net Income	₹ 4.05B	₹ -1.20B	₹ -2.21B	₹ -4.60B	₹ 2.55B
Balance Sheet
Cash & Short-Term Investments	₹ 2.06B	₹ 2.90B	₹ 3.61B	₹ 1.84B	₹ 2.75B
Total Assets	₹ 60.49B	₹ 58.40B	₹ 66.38B	₹ 69.76B	₹ 70.15B
Total Debt	₹ 18.80B	₹ 25.17B	₹ 30.30B	₹ 30.25B	₹ 23.48B
Net Debt	₹ 17.43B	₹ 23.56B	₹ 27.26B	₹ 28.54B	₹ 22.22B
Total Liabilities	₹ 34.62B	₹ 37.68B	₹ 44.66B	₹ 45.93B	₹ 42.01B
Stockholders' Equity	₹ 25.52B	₹ 21.26B	₹ 22.12B	₹ 23.59B	₹ 27.77B
Cash Flow
Free Cash Flow	₹ 4.42B	₹ 5.83B	₹ -505.27M	₹ -4.01B	₹ 1.84B
Operating Cash Flow	₹ 6.84B	₹ 7.01B	₹ 444.11M	₹ -2.58B	₹ 4.81B
Investing Cash Flow	₹ -896.89M	₹ -1.50B	₹ 3.02B	₹ -1.19B	₹ -5.21B
Financing Cash Flow	₹ -6.43B	₹ -6.93B	₹ -2.14B	₹ 4.21B	₹ -157.96M

Currency in INR

Strides Pharma Science Ltd Earnings and Revenue History

Income Statement >

Strides Pharma Science Ltd Debt to Assets

Balance Sheet >

Strides Pharma Science Ltd Cash Flow

Cash Flow >

Strides Pharma Science Ltd Forecast EPS vs Actual EPS

Earnings >